Oat-Based Snacks Market Opportunities by Key Players, Regional Segmentation and Forecasts, 2018 – 2025

PUNE, MAHARASHTRA, INDIA, May 23, 2018 /EINPresswire.com/ — Global Oat-Based Snacks Industry

New Study on “2018-2025 Oat-Based Snacks Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

Global Oat-Based Snacks market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
General Mills 
Kellogg 
Mondelez International 
Nairn's Oatcakes 
Quaker Oats Company 
Bobo's Oat Bars 
Britannia Industries 
Curate Snacks 
Pamela’s Products 
Seamild 

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3168866-global-oat-based-snacks-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oat-Based Snacks in these regions, from 2013 to 2025 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Oat-Based Bakery and Bars 
Oat-Based Savory 
Other 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Hypermarkets and Supermarkets 
Independent Retailers 
Convenience Stores 
Other

 Some points from table of content:

Global Oat-Based Snacks Market Research Report 2018 
1 Oat-Based Snacks Market Overview 
1.1 Product Overview and Scope of Oat-Based Snacks 
1.2 Oat-Based Snacks Segment by Type (Product Category) 
1.2.1 Global Oat-Based Snacks Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Oat-Based Snacks Production Market Share by Type (Product Category) in 2017 
1.2.3 Oat-Based Bakery and Bars 
1.2.4 Oat-Based Savory 
1.2.5 Other 
1.3 Global Oat-Based Snacks Segment by Application 
1.3.1 Oat-Based Snacks Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Hypermarkets and Supermarkets 
1.3.3 Independent Retailers 
1.3.4 Convenience Stores 
1.3.5 Other 
1.4 Global Oat-Based Snacks Market by Region (2013-2025) 
1.4.1 Global Oat-Based Snacks Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Oat-Based Snacks (2013-2025) 
1.5.1 Global Oat-Based Snacks Revenue Status and Outlook (2013-2025) 
1.5.2 Global Oat-Based Snacks Capacity, Production Status and Outlook (2013-2025)

2 Global Oat-Based Snacks Market Competition by Manufacturers 
2.1 Global Oat-Based Snacks Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Oat-Based Snacks Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Oat-Based Snacks Production and Share by Manufacturers (2013-2018) 
2.2 Global Oat-Based Snacks Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Oat-Based Snacks Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Oat-Based Snacks Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Oat-Based Snacks Market Competitive Situation and Trends 
2.5.1 Oat-Based Snacks Market Concentration Rate 
2.5.2 Oat-Based Snacks Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3168866-global-oat-based-snacks-market-research-report-2018

3 Global Oat-Based Snacks Capacity, Production, Revenue (Value) by Region (2013-2018) 
3.1 Global Oat-Based Snacks Capacity and Market Share by Region (2013-2018) 
3.2 Global Oat-Based Snacks Production and Market Share by Region (2013-2018) 
3.3 Global Oat-Based Snacks Revenue (Value) and Market Share by Region (2013-2018) 
3.4 Global Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.5 North America Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.6 Europe Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.7 China Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.8 Japan Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.9 Southeast Asia Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.10 India Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Oat-Based Snacks Supply (Production), Consumption, Export, Import by Region (2013-2018) 
4.1 Global Oat-Based Snacks Consumption by Region (2013-2018) 
4.2 North America Oat-Based Snacks Production, Consumption, Export, Import (2013-2018) 
4.3 Europe Oat-Based Snacks Production, Consumption, Export, Import (2013-2018) 
4.4 China Oat-Based Snacks Production, Consumption, Export, Import (2013-2018) 
4.5 Japan Oat-Based Snacks Production, Consumption, Export, Import (2013-2018) 
4.6 Southeast Asia Oat-Based Snacks Production, Consumption, Export, Import (2013-2018) 
4.7 India Oat-Based Snacks Production, Consumption, Export, Import (2013-2018)

5 Global Oat-Based Snacks Production, Revenue (Value), Price Trend by Type 
5.1 Global Oat-Based Snacks Production and Market Share by Type (2013-2018) 
5.2 Global Oat-Based Snacks Revenue and Market Share by Type (2013-2018) 
5.3 Global Oat-Based Snacks Price by Type (2013-2018) 
5.4 Global Oat-Based Snacks Production Growth by Type (2013-2018)

6 Global Oat-Based Snacks Market Analysis by Application 
6.1 Global Oat-Based Snacks Consumption and Market Share by Application (2013-2018) 
6.2 Global Oat-Based Snacks Consumption Growth Rate by Application (2013-2018) 
6.3 Market Drivers and Opportunities 
6.3.1 Potential Applications 
6.3.2 Emerging Markets/Countries

7 Global Oat-Based Snacks Manufacturers Profiles/Analysis 
7.1 General Mills 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Oat-Based Snacks Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 General Mills Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Kellogg 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Oat-Based Snacks Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Kellogg Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Mondelez International 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Oat-Based Snacks Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Mondelez International Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Nairn's Oatcakes 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Oat-Based Snacks Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Nairn's Oatcakes Oat-Based Snacks Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Quaker Oats Company 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Oat-Based Snacks Product Category, Application and Specification 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Healthcare Packaging Market – Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2025

Wiseguyreports.Com Publish New Market Report On -“Healthcare Packaging Market – Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2018 – 2025”

PUNE, INDIA, May 23, 2018 /EINPresswire.com/ —

Healthcare Packaging Market 2018

This report studies the global Healthcare Packaging market status and forecast, categorizes the global Healthcare Packaging market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa).

The major manufacturers covered in this report
Becton & Dickinson
Berry Plastics
Bilcare
CareFusion Corporation
Catalent
Alcan Packaging
Aldelphi Healthcare Packaging
American Packaging Corporation
AMGRAPH Packaging
Ball Plastics Packaging
Beacon Converters
Cato Software Solutions
Amcor
Gerresheimer
Schott
Alexander
Accudial Pharmaceutical
Admiral Packaging
Adelphi Healthcare Packaging
Air Packaging Technologies
Nypro Packaging
RPC Group
Steripack
Vitro
Winpak

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3185774-global-healthcare-packaging-market-research-report-2018

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan

Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Disposable Packaging
Reusable Packaging

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Medical Apparatus And Instruments
Medical Drugs
Medical Container
Other

Complete Report Details @ https://www.wiseguyreports.com/reports/3185774-global-healthcare-packaging-market-research-report-2018

Table of Contents –Analysis of Key Points

Global Healthcare Packaging Market Research Report 2018
1 Healthcare Packaging Market Overview
1.1 Product Overview and Scope of Healthcare Packaging
1.2 Healthcare Packaging Segment by Type (Product Category)
1.2.1 Global Healthcare Packaging Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Healthcare Packaging Production Market Share by Type (Product Category) in 2017
1.2.3 Disposable Packaging
1.2.4 Reusable Packaging
1.3 Global Healthcare Packaging Segment by Application
1.3.1 Healthcare Packaging Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Medical Apparatus And Instruments
1.3.3 Medical Drugs
1.3.4 Medical Container
1.3.5 Other
1.4 Global Healthcare Packaging Market by Region (2013-2025)
1.4.1 Global Healthcare Packaging Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Healthcare Packaging (2013-2025)
1.5.1 Global Healthcare Packaging Revenue Status and Outlook (2013-2025)
1.5.2 Global Healthcare Packaging Capacity, Production Status and Outlook (2013-2025)
………

7 Global Healthcare Packaging Manufacturers Profiles/Analysis
7.1 Becton & Dickinson
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Healthcare Packaging Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Becton & Dickinson Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Berry Plastics
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Healthcare Packaging Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Berry Plastics Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Bilcare
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Healthcare Packaging Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bilcare Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 CareFusion Corporation
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Healthcare Packaging Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 CareFusion Corporation Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Catalent
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Healthcare Packaging Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Catalent Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Alcan Packaging
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Healthcare Packaging Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Alcan Packaging Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Aldelphi Healthcare Packaging
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Healthcare Packaging Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Aldelphi Healthcare Packaging Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 American Packaging Corporation
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Healthcare Packaging Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 American Packaging Corporation Healthcare Packaging Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
Continued…..

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Wartburg’s Chairman of the Foundation Board Receives Distinguished Trustee Award

Dr. Nicholas Cicchetti and his wife Antoinette Cicchetti

Wartburg’s Chairman of the Foundation Board, Dr. Nicholas Cicchetti, Affectionately called “Dr. Nick”, recently received the 2018 Distinguished Trustee Award

Dr. Cicchetti’s diverse professional background and history with our organization make him a inimitable board member and we congratulate him on this honor.”

— David Gentner

MOUNT VERNON, NY, USA, May 22, 2018 /EINPresswire.com/ — Wartburg’s Chairman of the Foundation Board, Dr. Nicholas Cicchetti, Affectionately called “Dr. Nick”, recently received the 2018 Distinguished Trustee Award from United Hospital Fund – Tribute to Hospital and Health Care Trustees celebration. Dr. Nick’s award was given in honor of his leadership and service to Wartburg. The evening was dedicated to recognizing the dedication and leadership of the volunteer leaders who govern not-for-profit hospitals, nursing homes, and home care organizations throughout the New York metropolitan region. “I’m truly honored and humbled to be a recipient of such a great award” said Dr. Cicchetti.

Wartburg’s President and CEO, Dr. David J. Gentner explained with great enthusiasm his reasons for nominating Dr. Cicchetti, “Dr. Cicchetti’s diverse professional background and history with our organization make him a inimitable boardmember and we congratulate him on this honor,” said Dr. David Gentner, Wartburg’s President and CEO. “We appreciate his guidance and thoughtful deliberation as we continue to evolve to meet the care and housing needs of seniors in this region.”

Dr. Nicholas Cicchetti is a loyal steward of Wartburg’s mission, values and strategic assets. A board member since 2005, Dr. Cicchetti began his career at Wartburg as a part-time security guard. Fast forward thirty years he is currently the Chairman of Wartburg’s Foundation, the supporting endowment for Wartburg’s programs and services.

Angela Ciminello
Wartburg
914-513-5128
email us here


Source: EIN Presswire

Global Computational Medicine Market- Global Forecast, Market Overview, Manufacturing Cost Analysis, Marketing Strategy

HOUSTON, TEXAS, UNITED STATES, May 22, 2018 /EINPresswire.com/ — Computational medicine also called as scientific computing or scientific computation is defined as the mathematical model and computer aided model which is used to study how the process of disease development. It includes the use of the biological data to construct relation algorithms among different biological systems to understand the similarities and differences. It is application of computer simulation and forms of computation to solve the problems in scientific disciplines. Computational medicine supports both science and engineering problem solving. The foundation of computational medicine is based upon database and constraint-based models.

The report on the Global Computational Medicine Market is a complete overview of the market, covering various aspects product definition, segmentation based on various parameters, and the prevailing vendor landscape. It compiles in-depth information and research methodologies. It is also combined with relevant charts and tables to enable readers to get a better perspective of this global market.

Get Sample copy of this Report @: https://www.researchnreports.com/request_sample.php?id=1885

Companies Profiled in this report includes, Aurora Fine Chemicals LLC,Biognos AB,Certara LP.,Compugen Ltd.,Prosarix Ltd,Simulations Plus, Inc.,Schrodinger, LLC,FQS Poland,Labsolutions LLC, and others.

Information technology has been assisting the research organizations to enhance collaborative efforts, managing workflows, enabling dynamism in the processes, handling larger volumes of data and decision making. The time taken for drug discovery and development has been reduced considerably in the past two decades with the advent of fast, accurate and user friendly computational platforms. Cloud computing refers to computational platform/repository that allows remote access of large volumes of data which is available for few or more users.

The report takes a close and analytical look at the various companies that strive for a higher share of the global Computational Medicine market. For this purpose, a section dedicated to company profiles has been included in the report. The profiling of the leading players is done in order to judge the current competitive scenario.

Get 50% Discount on This Premium Report @: https://www.researchnreports.com/ask_for_discount.php?id=1885

The topographical subdivision of the Global Computational Medicine Market entails the prime regions in the market during the forecast period. Information on the province leading this market and the reasons for the sovereignty of this region are also some of the aspects featured under this section of the report.

As per the research study, the market is highly fragmented and competitive due to the presence of a number of contestants. This research study is aimed at presenting a clear picture of the global market to the readers in order to help them is gaining a better understanding of this market. The report’s conclusion reveals the overall scope of the Global Computational Medicine Market in terms of the viability of investments in the various segments of the market, along with an eloquent passage that outlines the viability of new projects that might succeed in the global market in the near future.

For More Information @: https://www.researchnreports.com/enquiry_before_buying.php?id=1885

Table of Contents

Global Computational Medicine Market Research Report

Chapter 1 Computational Medicine Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Smart Toilet Market Forecast

Sunny Denis
Research N Reports
+1 888-631-6977
email us here


Source: EIN Presswire

In Depth Assessment on Body Composition Analysis Market CAGR of +12% by 2023: Global Demand, Supply, Cost Structure

The demand for body composition analyzers has been on the rise due to the growing obese population across the globe.

HOUSTON, TEXAS, UNITED STATES, May 22, 2018 /EINPresswire.com/ — The Body Composition Analysis Market to Grow steadily at a CAGR of +12% during the forecast period.

Body Composition Analyzers (BCA) helps in measuring different compounds present within the body and furnishing of their respective values at the point of analysis. Some of the analyzers can project cumulative variations in body composition for a specific period. Moreover, specific BCA can determine an individual’s risk of developing certain disease as truncal and abdominal obesity besides skin fold measurements can be used for risk factor analysis in cohort studies for obesity-induced diseases. These factors will promote the growth of BCA in the global market on account of its wide range of applications in the arena of sports, medical research, especially causal association research studies in the disciplines of anthropology, nutrition, epidemiology etc.

A comprehensive analysis of the Global Body Composition Analysis Market has been conducted in this intelligence report. It includes the investigations carried out on the historical progressions, ongoing market scenarios, and future prospects. An accurate data of the products, strategies and market shares of leading companies in this particular market has been mentioned. This report presents a comprehensive overview of the competitive scenario of the global market. The report further projects the size and valuation of the global market throughout the forecast period.

Get a sample @: https://www.researchnreports.com/request_sample.php?id=15778

Companies Profiled in this report includes, GE Healthcare, Geratherm Medical AG, Hologic Inc., InBody Co. Ltd., Iworx Systems Inc., Jawon Medical Co. Ltd., KORR Medical Technologies Inc., Laica SpA, MGC Diagnostics Corporation, Microlife Medical Home Solutions Inc, Mindray Medical International Limited, Mortara Instrument Inc.

The body composition analyzers market is segmented on the basis of product, by end users and region. By product, the market comprises of Bio-impedance analyzers, Dual energy X-ray absorptiometry (DEXA), Skinfold calipers, Air displacement plethysmography (ADP), and Hydrostatic weighing. In 2018, bio-impedance analyzer is estimated to account for the largest share of the body composition analyzer market and is expected to grow at the highest rate during the forecast period. This large share can be attributed to the simplicity, low cost, and better accuracy as compared to other body composition analyzers.

The product and application segments of the global Body Composition Analysis market have also been studied in terms of their growth patterns in the coming years. The top players predicted to exhibit a significant share in the market have further been analyzed in the competitive landscape section of the study.

Get Reasonable Discount on this Report @: https://www.researchnreports.com/ask_for_discount.php?id=15778

This report is a full analysis which includes product type, applications, deployment, verticals, technology and regional segmentation. To gain a clear understanding of the breakdown of the Body Composition Analysis market, the report also reviews the performance of it’s in the market scenario, power. The report provides statistics for each key segment of the global market in order to shed light on the development patterns exhibited by the market. Latest figures illustrating the performance of the Body Composition Analysis market are provided in detail in the report in order to provide a granular picture of the market’s latest conditions.

For the better understanding of the market, after incoming of the overall market size, the analyst were able to accurately split the market into numerous segments. The broken-down market research report functioned as a basis to recognize the movements of Body Composition Analysis market in the global scenario and double checked data is offered to support every argument.

For More Information @: https://www.researchnreports.com/enquiry_before_buying.php?id=15778

Table of Contents

Global Body Composition Analysis Market Research Report

Chapter 1 Global Body Composition Analysis Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Market Forecast

Sunny Denis
Research N Reports
+1 888-631-6977
email us here


Source: EIN Presswire

CVR Medical Retains BUYINS.NET to Surveil Short Sellers and Market Makers

CVR Medical Corp. (OTCQB:CRRVF)

VANCOUVER, BRITISH COLUMBIA, CANADA, May 22, 2018 /EINPresswire.com/ —

CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on CVR Medical (OTCQB: CRRVF) (TSXV: CVM) (FSE: B3BN) after releasing the latest short sale data through May 17, 2018. The total aggregate number of shares shorted since January 2017 is approximately 14.37 million shares. Approximately 45.60% of daily trading volume is short selling. The SqueezeTrigger price for all CRRVF shares shorted is $0.38. A short squeeze is expected to begin when shares of CRRVF exceed this level.

Click here to view Report: http://www.buyins.com/reports/crrvf5-18-18.pdf
Click here for SqueezeTrigger: http://www.buyins.com/images2/crrvfstr5-18-18.jpg
Click here for Friction Factor: http://www.buyins.com/images2/crrvfff5-18-18.jpg
Click here for detailed explanation: http://www.buyins.com/brochure.pdf

Friction Factor calculates if a fair market is being made in the shares of CRRVF. 49% of the previous 35 trading days have been positive or bullish-biased and 51% have been negative or bearish-biased.

Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies for investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.

BUYINS.NET monitors CRRVF market-makers daily for compliance with Fair Market-Making Requirements.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the "Joint Venture"). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies and comparable valuations.

DISCLAIMER:

BUYINS.NET is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. CRRVF has paid $1,667 per month for six months of data provided in this and subsequent reports. CRRVF has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

For further information contact:

Peter Bakema, CEO, President and Director
Email: info@cvrmed.com
or
Marc S. Lubow.
Vice President Capital Markets, Investor Relations
marclubow@cvrmed.com
Telephone: (904) 923 – 4037
or
Brisco Capital Partners Corp.
Scott Brisco, President
Telephone: (403) 262-9888
or
BUYINS.NET
Thomas Ronk
800-715-9999
tomronk@gmail.com
http://www.buyins.net

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Peter Bakema
CVR Medical Corp.
734-718-5115
email us here


Source: EIN Presswire

National Association of County and City Health Officials (NACCHO) Reacts to the Santa Fe High School Shooting

Organization Represents Nation’s Nearly 3,000 Local Governmental Health Departments — Texas Public Health Official Umair A. Shah, MD, MPH Quoted

WASHINGTON, DC, UNITED STATES, May 22, 2018 /EINPresswire.com/ — In a scene all-too-frequent in our schools, ten people were killed last Friday in a mass shooting at Santa Fe High School in southeastern Texas. From a young man who had just turned 17 and was preparing to celebrate with friends to a Pakistani exchange student working to build bridges between her host and native countries, we are reminded of the vast promise that is lost when children become victims of a shooter’s outrage.

“This incident hits close to home, since this occurred in our neighboring community. Our hearts go out to all those affected,” said Umair A. Shah, MD, MPH, executive director of Harris County Public Health and NACCHO board president. “As a country we have not done enough to invest in research and response efforts in behavioral health and violence prevention. We can and must do more to emphasize and fund prevention efforts so we can protect our nation’s children. As a physician, public health practitioner, and a father, I know that we can and should be doing more.”

A recent article in Politico Pulse pointed out that the Centers for Disease Control and Prevention’s (CDC) ban to study gun violence has been quietly lifted, but in the ensuing two months, funding for firearms research at CDC is still nonexistent. “We shouldn’t have to wait for yet another shooting until funding for gun violence research becomes available to the CDC,” said NACCHO CEO, Lori Tremmel Freeman, MBA. “What is urgently needed is dedicated funding for data collection on a broad variety of issues aside from gun violence, including assault weapons, gun theft, suicide by gun, accidents, straw purchasers, background checks, guns on college campuses, and a host of other factors. Public health departments need to focus on prevention efforts in their communities, but the gaps in data make it difficult on where to focus those efforts.”

NACCHO wants to remind and urge its partners of the absolute importance of building resilient communities that strongly support each other, especially in times of crisis. As always, NACCHO remains committed to providing resources, training, and guidance to their local health department members to help in their response to this ongoing public health crisis. These include enhancing awareness through trainings for Suspicious Activity, Active Shooter and Explosive Device, and Risk Communications. You will find resources on NACCHO’s Preparedness blog here, and updated resources from the U.S. Department of Homeland Security can be found here.

###

About NACCHO
The National Association of County and City Health Officials (NACCHO) represents the nation’s nearly 3,000 local governmental health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit www.naccho.org.

Theresa Spinner
National Association of County and City Health Officials
202-783-5551
email us here


Source: EIN Presswire

The US Accounts for the Highest Number of Prevalent Cases of Spinal Muscular Atrophy (SMA), Finds New Report

Drug Pipeline Reports

Drug Pipeline Reports

Market Research Reports Inc.

Market Research Reports Inc.

The US have highest number of SMA amongst the 7 major markets whhich include France, Germany, Italy, Spain, United Kingdom and Japan

As per our estimation, the 7 major market size for SMA was estimated to be 825 Million in 2017.”

— DI

LEWES, DELAWARE, DELAWARE, UNITED STATES, May 22, 2018 /EINPresswire.com/ — Spinal Muscular Atrophy [SMA] is a rare hereditary neuromuscular disorder caused by Bi-allelic mutation of survival motor neuron gene 1 (SMN1). In healthy people this gene produces a protein required by the muscle controlling nerves. In the deficiency of this protein these nerve cells cannot function properly which leads to fatal muscle weakness. It is one of the most common causes of infant death and mobility impairment; the severity of diseases depends on the number of backup gene SMN2 that varies from 1-4 in SMA patients. Thus, SMA can be categorized into four sub-types on the basis of severity; SMA type 1 is the most severe form with highest mortality rate whereas SMA type 4 is the mildest form with lowest impairment.

There are very scarce studies that provide sufficient epidemiology data for SMA disorder, as a large pool of population is still undiagnosed. As per the current statistics, the incidence of SMA is 1 per 5,000 to 10,000 live births and 1 in 50 people are carriers of SMA causing faulty genes. According to DelveInsight estimates, there were 38,900 diagnosed prevalent SMA cases in 2017 in the 7MM.

The US accounts for the highest number of prevalent cases of SMA amongst the 7 major markets (7MM). Since SMA is a low incidence neurological disorder its diagnosis was difficult in historic years but with advancement in precise diagnostic techniques (like genetic testing and carrier testing) and supportive USFDA policies, The US has a noticeable growth diagnosed cases of SMA in the last couple of years. Report forecast suggests the diagnosed prevalence of 15,000 cases of SMA in the U.S. in 2017.

SMA is the second most common fatal disease in the U.S. after cystic fibrosis, with highest mortality in Type-1 patients (Infants) i.e., <2 years of age. There had been no cure for this deadly disease, prior to the approval of “Spinraza”, in December 2016. Spinraza, second antisense oligonucleotide to ever receive USFDA approval is the first and only therapy to be launched for SMA that targets all 3 major types of SMA.

The drug has been considered as a ray of hope for both doctors as well as the parents of infants suffering from SMA. But, the drug comes with a hefty price tag of $100,000 (20% discount) per injection, which leads to an annual cost of $600,000 for the first year of treatment and then $300,000 for the subsequent years. The developer company [Biogen, Inc.] is actively working along with the Government and SMA organizations, to come up with better reimbursement policies for Spinraza so that maximum patients could receive the benefit of drugs.

Despite of being the only therapy, Spinraza also has its own fair share of drawbacks and adverse events. For instance, the most common adverse reactions reported for Spinraza were upper respiratory infection, lower respiratory infection and constipation. Serious adverse reactions of atelectasis were more frequent in Spinraza-treated patients. Apart from these adverse effects, one of the major drawback for Spinraza is that it cannot be given to patients that are already on ventilation (as per the drug’s exclusion criteria).

The pharmaceutical companies, actively involved in the development of therapies that can help in treating SMA, are aware of the drawbacks and adverse events caused by the usage of Spinraza. They understand that there’s an urgent need for more and better treatment options for SMA. The emerging therapies that are expected to compete Spinraza include CK-2127107, RG7916, AVXS-101, Olesoxime and LMI070.

The launch of other better upcoming therapies and the drug’s patent expiry in 2023, shall negatively affect the market share of Spinraza, leading to slow & gradual decline in the revenue.

Spinal Muscular Atrophy (SMA) – Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Spinal Muscular Atrophy in the United States, EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of SMA from 2017 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to find best of the opportunities and assess underlying potential of the market.

Browse More : https://www.marketresearchreports.com/pharma-healthcare

Drug Pipeline Market Research Reports

About Market Research Reports, Inc.
Market Research Reports® Inc. is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global &regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Sudeep Chakravarty
Market Research Reports Inc.
+1-302-703-9904
email us here


Source: EIN Presswire

Dentures in Easton from Lehigh Valley Dentist Cost Only $650 Dollars

Dentist in Easton providing affordable dentures and dental implants.

Affordable Dental Solutions is offering the city of Easton dentures and dental implants at affordable prices.

Our team will work with patients to ensure that they’re receiving the best solution for their health and their smile.”

— Dr. Gary Greenberg

EASTON, PENNSYLVANIA, UNITED STATES, May 22, 2018 /EINPresswire.com/ — Affordable Dental Solutions (ADS) is ensuring that affordable dentures are available in the Lehigh Valley. While other dentists may charge thousands for dentures, the team at ADS is dedicated to high-quality care at low-cost prices.

Full dentures in Easton from ADS cost only $650 per arch. Meanwhile, partial dentures cost only $750 per arch.

ADS also offers implant-retained dentures for only $2,999 when two dental implants and attachments are added to a patient’s current pair of dentures.

“Our team will work with patients to ensure that they’re receiving the best solution for their health and their smile,” says Dr. Gary Greenberg, dentist in Easton.

ADS also offers affordable dental implants in Easton. Dental implants cost only $2,000 and include both the abutment and crown for a seamless finish.

To learn more about the missing tooth solutions available at ADS, request an appointment with the team of Lehigh Valley dentists: http://www.eastonimplants.com/appointment.html.

About Affordable Dental Solutions: Based in Eastern Pennsylvania, Affordable Dental Solutions is a provider of full dentistry services. For nearly a decade, Affordable Dental Solutions has offered patients procedures such as dental implants, crowns, and dentures at rates much lower than area competitors by utilizing state-of-the-art equipment and by negotiating discounts with implant manufacturing companies. Learn more at http://www.affordabledentalsolutions.com/.

Jamie Jaskolka
Affordable Dental Solutions
(484) 948-2900
email us here

Patient Care Philosophy at Affordable Dental Solutions in Easton


Source: EIN Presswire

Football and Family: First Citizens Bank Partnership to Support Teen Cancer America at the 2018 Charlotte Kickoff Night

CHARLOTTE, NC, UNITED STATES, May 22, 2018 /EINPresswire.com/ — Scholastic Sports Marketing, LLC (SSM) has announced a new community partnership with North Carolina-headquartered First Citizens Bank, the largest family-controlled bank in the United States, for the 2018 Charlotte Kickoff Night at Memorial Stadium on August 18, 2018. The partnership will raise awareness and funds for Teen Cancer America, a national nonprofit that works with medical centers to develop teen-friendly environments and specialized services and care for young people with cancer. Opportunities to donate to Teen Cancer America will be available throughout the event, on-site and online.

“This event is a tremendous opportunity to bring attention to the needs of teens fighting cancer,” said Jeff Ward, who is on the board of directors for Teen Cancer America and is chief strategy officer for First Citizens Bank. “They’re too old for the children’s hospital, too young for the adult wards and need specialized units and programs designed especially for them. We appreciate the support of SSM and all the students and teams who will participate in this exciting evening of high school football in Charlotte.”

The 2018 Charlotte Kickoff Night game schedule is as follows:

Scotland High vs. Butler High – 5:00pm
Mallard Creek High vs. Dutch Fork High – 8:00pm

Both match-ups will feature schools with proud, winning traditions. Collectively, the four teams have won ten state championships with a combined record of 97-13 over the past two seasons. Fans, of all ages, from the greater Charlotte Metro area are encouraged to join us for the one and only Saturday night kickoff to the 2018 high school football season.

Since 2015, First Citizens Bank has been a major advocate and sponsor of Teen Cancer America, which was co-founded by Roger Daltrey, legendary front man of The Who. Daltrey also recorded a new version of the hit song “Let My Love Open The Door” exclusively for First Citizens Bank and Teen Cancer America. The song is the cornerstone of the bank’s awareness campaign for the nonprofit. The campaign asks people to “open the door” and help teens with cancer.

“We are grateful for First Citizens Bank’s support of our 2018 ‘Charlotte Kickoff Night powered by OrthoCarolina’ event and for National Amateur Sports assistance in bringing us together. This partnership will be a success because each organization values the health and well-being of the youth in our community first and foremost,” stated Scholastic Sports Marketing President, James Companion. “SSM and NAS are proud to count First Citizens as the official bank of our 6th annual Kickoff Night event!”

For more information about the 2018 Charlotte Kickoff Night, click here.

About First Citizens Bank:

First Citizens Bank’s sponsorship of Teen Cancer America is its largest-ever corporate philanthropic initiative. The goal is to raise funds, build awareness and partner with hospitals and medical centers to establish new teen cancer units and programs. For more information, visit LetMyLoveOpenTheDoor.com. Founded in 1898, First Citizens Bank (firstcitizens.com) is the largest family-controlled bank in the U.S., with offices in 19 states. First Citizens Bank is a wholly-owned subsidiary of First Citizens BancShares Inc. (Nasdaq: FCNCA), which has more than $34 billion in assets. First Citizens Bank. Forever First®.

About Scholastic Sports Marketing:

Charlotte, NC based Scholastic Sports Marketing is one of America's fastest growing high school multimedia and marketing management companies. SSM represents some of the nation's top scholastic properties including the nationally televised Shrine Bowl of the Carolinas, large athletic conferences, state associations and some of the most prominent high schools in the country.

Scholastic Sports Marketing’s mission is to enhance the overall experience for high school student-athletes by developing new revenue streams while fostering the image and awareness level of the athletic events, conferences and institutions in which they participate.

Visit Scholastic Sports Marketing on the web at www.SSMllc.com.

About National Amateur Sports:

National Amateur Sports (NAS) is a full-service sports marketing firm focused on growing amateur athletics programs. By leveraging technology, NAS eases administrative burdens and enriches the quality of school’s media assets. The improved platform drives traffic and attracts community partners eager to reach this valued demographic through targeted marketing campaigns and community good will. These partnerships generate much needed revenue for interscholastic sports.

Ashley Osiecki
National Amateur Sports
704-341-4645
email us here


Source: EIN Presswire